Nathan J. Dowden

Companies

• Entrada Therapeutics, Inc.Chief operating officer Oct 28, 2021 to now¹
• Entrada Therapeutics, Inc.President Mar 5, 2024 to Oct 18, 2024²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ETEntrada Therapeutics, Inc. TRDA196,060 shares³$943.0K at $4.81Sep 2, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 2, 2026Shares withheld for tax 2,528 shares at $7.14 of Entrada Therapeutics, Inc.³
• May 4, 2026Sold 15,000 shares at $15.33 of Entrada Therapeutics, Inc.⁴
• May 4, 2026Exercised options 15,000 shares at $1.74 of Entrada Therapeutics, Inc.⁴
• Mar 10, 2026Sold 11,894 shares at $13.05 of Entrada Therapeutics, Inc.⁵
• Mar 9, 2026Sold 3,116 shares at $13.02 of Entrada Therapeutics, Inc.⁵
• Mar 3, 2026Shares withheld for tax 14,038 shares at $11.76 of Entrada Therapeutics, Inc.⁶
• Mar 2, 2026Shares withheld for tax 7,223 shares at $11.66 of Entrada Therapeutics, Inc.⁶
• Mar 1, 2026Granted 55,800 shares of Entrada Therapeutics, Inc.⁶
• Sep 2, 2025Shares withheld for tax 1,746 shares at $5.43 of Entrada Therapeutics, Inc.⁷
• Mar 3, 2025Shares withheld for tax 5,144 shares at $11.68 of Entrada Therapeutics, Inc.⁸
• Mar 1, 2025Granted 60,800 shares of Entrada Therapeutics, Inc.⁸
• Sep 26, 2024Sold 847 shares at $16.00 of Entrada Therapeutics, Inc.⁹
• Sep 9, 2024Sold 1,904 shares at $15.07 of Entrada Therapeutics, Inc.¹⁰
• Sep 6, 2024Sold 399 shares at $15.19 of Entrada Therapeutics, Inc.¹⁰
• Sep 5, 2024Shares withheld for tax 171 shares at $15.13 of Entrada Therapeutics, Inc.¹¹
• Sep 4, 2024Shares withheld for tax 983 shares at $15.42 of Entrada Therapeutics, Inc.¹¹
• Sep 3, 2024Shares withheld for tax 15 shares at $17.70 of Entrada Therapeutics, Inc.¹¹
• Sep 3, 2024Shares withheld for tax 156 shares at $16.93 of Entrada Therapeutics, Inc.¹¹
• Sep 3, 2024Shares withheld for tax 483 shares at $15.76 of Entrada Therapeutics, Inc.¹¹
• Aug 16, 2024Sold 502 shares at $16.70 of Entrada Therapeutics, Inc.¹²
• Aug 16, 2024Sold 26,595 shares at $16.26 of Entrada Therapeutics, Inc.¹²
• Aug 16, 2024Exercised options 20,000 shares at $1.74 of Entrada Therapeutics, Inc.¹²
• Mar 6, 2024Sold 1,826 shares at $12.32 of Entrada Therapeutics, Inc.¹³
• Mar 5, 2024Shares withheld for tax 1,486 shares at $12.28 of Entrada Therapeutics, Inc.¹⁴
• Mar 4, 2024Shares withheld for tax 409 shares at $13.37 of Entrada Therapeutics, Inc.¹⁴